A meta-analysis on primary immune thrombocytopenia strongly suggested that LA positivity, but not aCL antibodies or anti-β2GP-I antibodies, has an increased thrombosis risk (25). The gene discussed is ACLY; the disease is autoimmune thrombocytopenic purpura.